Codes / ICD10CM / C83.75

C83.75 Burkitt lymphoma, lymph nodes of inguinal region and lower limb

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Burkitt lymphoma, lymph nodes of inguinal region and lower limb
  • Medical term: Burkitt's lymphoma

Summary

Burkitt lymphoma is a highly aggressive form of non-Hodgkin lymphoma that primarily affects B-cells in the lymphatic system. This subtype involves the lymph nodes located in the inguinal region and lower limb. It is characterized by rapid tumor growth and is often associated with specific genetic and viral factors. Early diagnosis and treatment are critical due to its fast progression.

Causes

The exact causes of Burkitt lymphoma are not fully understood, but it is strongly linked to infection with the Epstein-Barr virus (EBV). Genetic mutations, particularly chromosomal translocations involving the MYC gene, are also key contributors to its development.

Risk Factors

  • Epstein-Barr virus (EBV) infection
  • Human immunodeficiency virus (HIV) infection
  • Weakened immune system from other conditions or treatments
  • Young age, especially in children and young adults
  • Geographic regions with high EBV prevalence, such as equatorial Africa

Symptoms

  • Rapidly growing, painless lymph node swelling in the inguinal region or lower limb
  • Fever
  • Night sweats
  • Unexplained weight loss
  • Fatigue
  • Possible swelling or discomfort in the affected limb

Diagnosis

Diagnosis involves a physical examination to assess lymph node or organ swelling, followed by imaging tests (e.g., CT or MRI) to identify tumor locations. A biopsy of affected tissue is performed to confirm the presence of cancerous cells and determine the specific subtype. Additional tests, such as blood work or bone marrow biopsy, may be used to evaluate disease spread.

Treatment Options

Treatment typically involves intensive chemotherapy regimens, often including combinations of multiple drugs. For localized disease, radiation therapy may be used. In some cases, targeted therapies or immunotherapy may be considered. Treatment plans are tailored to the patient's overall health and disease stage.

Prognosis and Follow-Up

With prompt and appropriate treatment, the prognosis for Burkitt lymphoma can be favorable, especially in younger patients. However, the aggressive nature of the disease requires close monitoring. Follow-up care includes regular imaging and blood tests to check for recurrence. Long-term survivors may require ongoing surveillance for late effects of treatment.

Complications

  • Tumor lysis syndrome (due to rapid cell death during treatment)
  • Infection risk from weakened immune system
  • Organ dysfunction if lymphoma spreads to vital organs
  • Long-term side effects from chemotherapy or radiation

Lifestyle & Prevention

  • Maintain a healthy immune system through balanced nutrition and regular exercise.
  • Avoid known risk factors, such as unprotected exposure to EBV (where applicable).
  • Seek prompt medical attention for persistent or unusual symptoms.

When to Seek Professional Help

Consult a healthcare provider if you experience:

  • Rapidly enlarging lymph nodes in the inguinal region or lower limb.
  • Unexplained fever, night sweats, or weight loss.
  • Persistent fatigue or discomfort in the affected area.

Tips for Medical Coders

Use this code for documentation of Burkitt lymphoma specifically involving the lymph nodes of the inguinal region and lower limb. Ensure the medical record supports the anatomical location to justify code assignment. Verify that the diagnosis aligns with the clinical presentation and any biopsy or imaging results.

Book a walkthrough

C83.75 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.